标题
Colorectal cancer vaccines: The current scenario and future prospects
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-08-03
DOI
10.3389/fimmu.2022.942235
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse
- (2022) Jimmy Charneau et al. CANCER SCIENCE
- In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
- (2022) Hirokazu Okada et al. Scientific Reports
- Emerging vaccine nanotechnology: From defense against infection to sniping cancer
- (2022) Chan Feng et al. Acta Pharmaceutica Sinica B
- Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
- (2022) Lindsey Carlsen et al. Cancers
- Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
- (2022) Cong Liu et al. Frontiers in Cell and Developmental Biology
- Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
- (2022) Yue Zheng et al. DISEASE MARKERS
- A pH-/Enzyme-Responsive Nanoparticle Selectively Targets Endosomal Toll-like Receptors to Potentiate Robust Cancer Vaccination
- (2022) Heming Xia et al. NANO LETTERS
- Tumor RNA transfected DCs derived from iPS cells elicit cytotoxicity against cancer cells induced from colorectal cancer patients in vitro
- (2022) Shimpei Maruoka et al. Scientific Reports
- T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C
- (2022) John C. Flickinger et al. Frontiers in Immunology
- Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria
- (2022) Yale Yue et al. Nature Biomedical Engineering
- Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
- (2022) John C. Flickinger et al. npj Vaccines
- Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy
- (2021) Yu Zhang et al. ADVANCED MATERIALS
- Gutting it Out
- (2021) Carolina Mendonça Gorgulho et al. JOURNAL OF IMMUNOTHERAPY
- Cancer Immunoprevention: Current Status and Future Directions
- (2021) Mahsa Keshavarz-Fathi et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Nanobiomaterial-based vaccination immunotherapy of cancer
- (2021) Fangmin Chen et al. BIOMATERIALS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer
- (2021) Yaojun Yu et al. Human Vaccines & Immunotherapeutics
- A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint
- (2021) Katherine M. Bever et al. Clinical Epigenetics
- Engineering a sustained release vaccine with a pathogen-mimicking manner for robust and durable immune responses
- (2021) Yingying Hou et al. JOURNAL OF CONTROLLED RELEASE
- Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
- (2021) Keman Cheng et al. Nature Communications
- Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
- (2021) Junhua Mai et al. Advanced Science
- Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
- (2021) Sarah I. M. Sutherland et al. Frontiers in Immunology
- Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
- (2021) Mariam Oladejo et al. Frontiers in Immunology
- Adjuvant properties of IFN-γ and GM-CSF in the scFv6.C4 DNA vaccine against CEA-expressing tumors
- (2021) Bianca Ferrarini Zanetti et al. GENE THERAPY
- A recombinant Chinese measles virus vaccine strain rMV-Hu191 inhibits human colorectal cancer growth through inducing autophagy and apoptosis regulating by PI3K/AKT pathway
- (2021) Chu-di Zhang et al. Translational Oncology
- Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration
- (2021) Milda Naciute et al. VACCINE
- Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
- (2021) Lauren R. Corulli et al. Frontiers in Immunology
- Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
- (2021) Ding-Kang Wang et al. Frontiers in Immunology
- Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
- (2021) Erkko Ylösmäki et al. Journal for ImmunoTherapy of Cancer
- Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment
- (2021) Rani Chudasama et al. Vaccines
- Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
- (2021) Jiachen Li et al. ADVANCED MATERIALS
- Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model
- (2021) Johannes Gebert et al. GASTROENTEROLOGY
- Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials ( LICC , CELIM , FIRE ‐3)
- (2021) Markus Moehler et al. INTERNATIONAL JOURNAL OF CANCER
- Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
- (2021) Li-Feng Hu et al. Frontiers in Oncology
- Advancements in prophylactic and therapeutic nanovaccines
- (2020) Prateek Bhardwaj et al. Acta Biomaterialia
- Cancer vaccines: Targeting KRAS-driven cancers
- (2020) Ying Zhang et al. Expert Review of Vaccines
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
- (2020) Antonio Di Grazia et al. Cancers
- A genetic vaccine encoding shared cancer neoantigens to treat tumors with Microsatellite Instability.
- (2020) Guido Leoni et al. CANCER RESEARCH
- Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer
- (2020) Milda Naciute et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine
- (2020) Mei Guo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel
- (2020) Feihu Wang et al. Nature Biomedical Engineering
- Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer
- (2020) Victoria M. Kim et al. JCI Insight
- The Landscape of Tumor-Specific Antigens in Colorectal Cancer
- (2020) Nurul Ainaa Adilah Rus Bakarurraini et al. Vaccines
- Colorectal Tumor Microenvironment‐Activated Bio‐Decomposable and Metabolizable Cu 2 O@CaCO 3 Nanocomposites for Synergistic Oncotherapy
- (2020) Mengyu Chang et al. ADVANCED MATERIALS
- Chemical Strategies to Boost Cancer Vaccines
- (2020) Wen-Hao Li et al. CHEMICAL REVIEWS
- The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
- (2020) Alexej Ballhausen et al. Nature Communications
- Single-cell derived tumor organoids display diversity in HLA class I peptide presentation
- (2020) Laura C. Demmers et al. Nature Communications
- Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
- (2020) Vladimir Roudko et al. CELL
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Dendritic cell vaccine therapy for colorectal cancer
- (2020) Amanda L. Wooster et al. PHARMACOLOGICAL RESEARCH
- A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer
- (2020) Na Wang et al. Molecular Therapy-Oncolytics
- IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer
- (2020) Lili Deng et al. ONCOLOGY RESEARCH
- Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
- (2019) Adam E. Snook et al. Journal for ImmunoTherapy of Cancer
- Vaccinations for Colorectal Cancer: Progress, Strategies, and Novel Adjuvants
- (2019) Stephen Jiang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses
- (2019) Xiang Liu et al. BIOMATERIALS
- A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
- (2019) Mark Yarchoan et al. Cancer Medicine
- Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations
- (2018) Allen Cohn et al. JOURNAL OF IMMUNOTHERAPY
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates
- (2018) Mei Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
- (2018) Javier Rodriguez et al. Journal for ImmunoTherapy of Cancer
- Fungal vaccines, mechanism of actions and immunology: A comprehensive review
- (2018) Sanam Nami et al. BIOMEDICINE & PHARMACOTHERAPY
- Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
- (2018) Brendan Bulik-Sullivan et al. NATURE BIOTECHNOLOGY
- Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
- (2018) Sandra Wagner et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
- (2017) Jason Lohmueller et al. PHARMACOLOGY & THERAPEUTICS
- Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
- (2017) M. Morse et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas
- (2016) Megan C. Duggan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
- (2016) Mutsunori Murahashi et al. CLINICAL IMMUNOLOGY
- Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions
- (2016) John Berry et al. Expert Review of Clinical Immunology
- Computational genomics tools for dissecting tumour–immune cell interactions
- (2016) Hubert Hackl et al. NATURE REVIEWS GENETICS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
- (2015) C. R. Heery et al. Cancer Immunology Research
- Is the "3+3" Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design
- (2014) O. E. Rahma et al. CLINICAL CANCER RESEARCH
- A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
- (2014) Shoichi Hazama et al. Journal of Translational Medicine
- Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
- (2013) Marijo Bilusic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
- (2013) Michael A. Morse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Live-attenuated bacteria as a cancer vaccine vector
- (2013) Bertrand Toussaint et al. Expert Review of Vaccines
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
- (2012) T. Kimura et al. Cancer Prevention Research
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
- (2010) Elizabeth S. Gabitzsch et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?
- (2010) Kevin S Clive et al. Expert Review of Vaccines
- An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
- (2010) Michael A. Morse et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
- (2009) H. C. Toh et al. CLINICAL CANCER RESEARCH
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
- (2008) H. L. Kaufman et al. CLINICAL CANCER RESEARCH
- Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
- (2008) J. L. Gulley et al. CLINICAL CANCER RESEARCH
- An MVA-based Vaccine Targeting the Oncofetal Antigen 5T4 in Patients Undergoing Surgical Resection of Colorectal Cancer Liver Metastases
- (2008) Eyad Elkord et al. JOURNAL OF IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now